Stefàno, E.; De Castro, F.; Ali, A.; Benedetti, M.; Fanizzi, F.P.
The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes. Molecules 2025, 30, 3828.
https://doi.org/10.3390/molecules30183828
AMA Style
Stefàno E, De Castro F, Ali A, Benedetti M, Fanizzi FP.
The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes. Molecules. 2025; 30(18):3828.
https://doi.org/10.3390/molecules30183828
Chicago/Turabian Style
Stefàno, Erika, Federica De Castro, Asjad Ali, Michele Benedetti, and Francesco Paolo Fanizzi.
2025. "The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes" Molecules 30, no. 18: 3828.
https://doi.org/10.3390/molecules30183828
APA Style
Stefàno, E., De Castro, F., Ali, A., Benedetti, M., & Fanizzi, F. P.
(2025). The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes. Molecules, 30(18), 3828.
https://doi.org/10.3390/molecules30183828